1. Home
  2. DOMH vs CHEK Comparison

DOMH vs CHEK Comparison

Compare DOMH & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMH
  • CHEK
  • Stock Information
  • Founded
  • DOMH 1967
  • CHEK 2004
  • Country
  • DOMH United States
  • CHEK Israel
  • Employees
  • DOMH 28
  • CHEK N/A
  • Industry
  • DOMH Biotechnology: Pharmaceutical Preparations
  • CHEK Medical Electronics
  • Sector
  • DOMH Health Care
  • CHEK Health Care
  • Exchange
  • DOMH Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • DOMH 74.9M
  • CHEK 9.0M
  • IPO Year
  • DOMH N/A
  • CHEK 2015
  • Fundamental
  • Price
  • DOMH $11.94
  • CHEK $0.86
  • Analyst Decision
  • DOMH
  • CHEK
  • Analyst Count
  • DOMH 0
  • CHEK 0
  • Target Price
  • DOMH N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • DOMH 4.1M
  • CHEK 70.6K
  • Earning Date
  • DOMH 03-31-2025
  • CHEK 02-25-2025
  • Dividend Yield
  • DOMH N/A
  • CHEK N/A
  • EPS Growth
  • DOMH N/A
  • CHEK N/A
  • EPS
  • DOMH N/A
  • CHEK N/A
  • Revenue
  • DOMH $12,589,000.00
  • CHEK N/A
  • Revenue This Year
  • DOMH N/A
  • CHEK N/A
  • Revenue Next Year
  • DOMH N/A
  • CHEK N/A
  • P/E Ratio
  • DOMH N/A
  • CHEK N/A
  • Revenue Growth
  • DOMH 1117.50
  • CHEK N/A
  • 52 Week Low
  • DOMH $0.83
  • CHEK $0.56
  • 52 Week High
  • DOMH $13.58
  • CHEK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • DOMH 82.78
  • CHEK 41.78
  • Support Level
  • DOMH $6.31
  • CHEK $0.81
  • Resistance Level
  • DOMH $13.58
  • CHEK $0.97
  • Average True Range (ATR)
  • DOMH 1.72
  • CHEK 0.10
  • MACD
  • DOMH 1.00
  • CHEK -0.02
  • Stochastic Oscillator
  • DOMH 86.16
  • CHEK 13.42

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: